Tannaz Eslamparast
Tannaz Eslamparast
Department of Medicine, University of Alberta
Bekræftet mail på ualberta.ca
Titel
Citeret af
Citeret af
År
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
T Eslamparast, H Poustchi, F Zamani, M Sharafkhah, R Malekzadeh, ...
The American journal of clinical nutrition 99 (3), 535-542, 2014
2972014
Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study
T Eslamparast, F Zamani, A Hekmatdoost, M Sharafkhah, S Eghtesad, ...
British journal of nutrition 112 (3), 438-445, 2014
802014
Dietary composition independent of weight loss in the management of non-alcoholic fatty liver disease
T Eslamparast, P Tandon, M Raman
Nutrients 9 (8), 800, 2017
732017
Probiotics and nonalcoholic fatty liver disease
T Eslamparast, S Eghtesad, A Hekmatdoost, H Poustchi
Middle East journal of digestive diseases 5 (3), 129, 2013
702013
Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study
Z Yari, M Rahimlou, T Eslamparast, N Ebrahimi-Daryani, H Poustchi, ...
International journal of food sciences and nutrition 67 (4), 461-469, 2016
612016
Sarcopenic obesity in cirrhosis—the confluence of 2 prognostic titans
T Eslamparast, AJ Montano‐Loza, M Raman, P Tandon
Liver International 38 (10), 1706-1717, 2018
592018
Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease
A Hekmatdoost, A Shamsipour, M Meibodi, N Gheibizadeh, ...
International journal of food sciences and nutrition 67 (8), 1024-1029, 2016
572016
Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study
T Eslamparast, M Sharafkhah, H Poustchi, M Hashemian, SM Dawsey, ...
International journal of epidemiology 46 (1), 75-85, 2017
532017
Egg consumption and risk of non-alcoholic fatty liver disease
Z Mokhtari, H Poustchi, T Eslamparast, A Hekmatdoost
World journal of hepatology 9 (10), 503, 2017
272017
Systematic review of nutrition screening and assessment in inflammatory bowel disease
S Li, M Ney, T Eslamparast, B Vandermeer, KP Ismond, K Kroeker, ...
World journal of gastroenterology 25 (28), 3823, 2019
222019
Are predictive energy expenditure equations accurate in cirrhosis?
T Eslamparast, B Vandermeer, M Raman, L Gramlich, V Den Heyer, ...
Nutrients 11 (2), 334, 2019
182019
Association of pro-inflammatory dietary intake and non-alcoholic fatty liver disease: findings from Iranian case-control study
F Vahid, N Shivappa, A Hekmatdoost, JR Hebert, H Poustchi, ...
International Journal for Vitamin and Nutrition Research, 2019
112019
Legume intake and risk of nonalcoholic fatty liver disease
A Bahrami, F Teymoori, T Eslamparast, G Sohrab, E Hejazi, H Poustchi, ...
Indian Journal of Gastroenterology 38 (1), 55-60, 2019
72019
A112 THE VALIDITY OF PATIENT-LED SELF-SCREENS FOR IDENTIFYING MALNUTRITION IN INFLAMMATORY BOWEL DISEASE
T Eslamparast, K Farhat, L Taylor, N Shommu, A Kumar, Q Fitzgerald, ...
Journal of the Canadian Association of Gastroenterology 1 (suppl_2), 170-171, 2018
12018
A235 systematic review and meta-analysis: comparing of estimated energy requirements in cirrhotic patients using indirect calorimetry versus prediction equations
T Eslamparast, B Vandermeer, M Raman, V Mathiesen, D Belland, M Ma, ...
Journal of the Canadian Association of Gastroenterology 1 (suppl_1), 411-412, 2018
12018
Effects of synbiotic supplementation on nonalcoholic fatty liver disease: PR0432 Metabolic Liver Diseases (NASH, etc.)
H POUSTCHI, T ESLAMPARAST, F ZAMANI, M SHARAFKHAH, ...
Journal of Gastroenterology and Hepatology 28, 850-851, 2013
12013
The effects of dietary synbiotic supplementation on the liver enzymes, inflammatory markers and hepatic fibrosis in patients with nonalcoholic fatty liver disease: a double …
T Eslamparast, H Poustchi, F Zamani, M Sharafkhah, R Malekzadeh, ...
Iranian Journal of Nutrition Sciences & Food Technology 8 (2), 1-8, 2013
12013
Using patient completed screening tools to predict risk of malnutrition in patients with Inflammatory Bowel Disease
LM Taylor, T Eslamparast, K Farhat, K Kroeker, B Halloran, N Shommu, ...
Crohn's & Colitis 360 3 (3), otab043, 2021
2021
Assessing Patient Proficiency with Internet-Connected Technology and Their Preferences for E-Health in Cirrhosis
KP Ismond, T Eslamparast, K Farhat, M Stickland, JC Spence, RJ Bailey, ...
Journal of medical systems 45 (7), 1-9, 2021
2021
A317 A SYSTEMATIC REVIEW OF NUTRITION SCREENING, NUTRITION ASSESSMENT AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE
S Li, M Ney, T Eslamparast, M Raman, P Tandon
Journal of the Canadian Association of Gastroenterology 1 (suppl_2), 456-457, 2018
2018
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20